# PTC THERAPEUTICS, INC.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/ptc-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 22 |
| Claims under review | 2 |
| Evidence records | 13 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-11-13T04:45:39.887074+00:00 |
| Last reviewed | 2026-11-13T04:45:39.887074+00:00 |

## Identity

- Legal name: PTC THERAPEUTICS, INC.
- Display name: PTC THERAPEUTICS, INC.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| As of | 2026-11-13T04:45:39.887074+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.769 |
| Directors | 4 |
| Committees | 2 |
| Governance events | 2 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Jessica Chutter: Director. Status: current. Independent: true. Since: 2026-01-01. claim_id=alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:8
- Jerome B. Zeldis: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:7
- Mark Klein: Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:9
- Stephanie S. Okey: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. Committees: Nominating and Governance (chair); Nominating and Governance · Chair (member). claim_id=alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:10

## Committees

- Nominating and Governance (nominating_governance). Chair: Stephanie S. Okey. Members: Stephanie S. Okey (chair, current); Jerome B. Zeldis (member, current). committee_id=alpha:committee:ptc-therapeutics-inc:nominating-and-governance
- Nominating and Governance · Chair (nominating_governance). Chair: NOT_PUBLISHED. Members: Stephanie S. Okey (member, unknown). committee_id=alpha:committee:ptc-therapeutics-inc:nominating-and-governance-chair

## Executive leadership

- Mark Klein: Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:17
- Christine Utter: Senior Vice President, Chief Accounting Officer & Head of People Services [CAO]. Status: unknown. claim_id=alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:11
- Eric Pauwels: Chief Business Officer. Status: unknown. claim_id=alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:12
- Jane Baj: Vice President of Corporate Communications. Status: unknown. claim_id=alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:13
- Lee Golden: Executive Vice President & Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:14
- Linda Montella Carter: Senior VP & Chief Information Officer [CIO]. Status: unknown. claim_id=alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:15
- Mark Elliott Boulding: Executive VP & Chief Legal Officer [GC]. Status: unknown. claim_id=alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:16
- Matthew Klein: CEO & Director [CEO]. Status: unknown. claim_id=alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:18
- Neil Almstead: Chief Technical Operations Officer. Status: unknown. claim_id=alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:19
- Pierre Gravier: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:20

## Governance events

- CEO_ROLE_RECORDED: Mark Klein executive of PTC THERAPEUTICS, INC., effective 2026-04-20. Effective: 2026-04-20. Detected: 2026-11-13T04:45:39.887074+00:00. event_id=alpha:event:transition:1pdtfntqhutul
- DIRECTOR_APPOINTED: Jessica Chutter seat on PTC THERAPEUTICS, INC., effective 2026-01-01. Effective: 2026-01-01. Detected: 2026-11-13T04:45:39.887074+00:00. event_id=alpha:event:transition:1qsxr0y1piwq3u

## Scoped resources

- `alpha://company/ptc-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record
- `alpha://company/ptc-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=identity
- `alpha://company/ptc-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=corporate-structure
- `alpha://company/ptc-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=board
- `alpha://company/ptc-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=committees
- `alpha://company/ptc-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=leadership
- `alpha://company/ptc-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=ownership
- `alpha://company/ptc-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=financials
- `alpha://company/ptc-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=capital-structure
- `alpha://company/ptc-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=compensation
- `alpha://company/ptc-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=governance
- `alpha://company/ptc-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=shareholder-governance
- `alpha://company/ptc-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=audit
- `alpha://company/ptc-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=legal
- `alpha://company/ptc-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=risk
- `alpha://company/ptc-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=cyber
- `alpha://company/ptc-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=ai-governance
- `alpha://company/ptc-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=agents
- `alpha://company/ptc-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=ecosystem
- `alpha://company/ptc-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=events
- `alpha://company/ptc-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=relationships
- `alpha://company/ptc-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=assessments
- `alpha://company/ptc-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:stephanie-s-okey","name":"Stephanie S. Okey"},"source_id":"board_seats"}`
- Claim alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:jerome-b-zeldis","name":"Jerome B. Zeldis"},"source_id":"board_seats"}`

## Leadership

- Jerome B. Zeldis: Director, Nominating and Governance. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fd5013e6bfde7a00d6c0ad2b5e4f3ddfde0d076393d208d92be274ba3cb9553c.
- Jessica Chutter: Director. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:8. Valid from: 2026-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fd5013e6bfde7a00d6c0ad2b5e4f3ddfde0d076393d208d92be274ba3cb9553c.
- Mark Klein: Director. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fd5013e6bfde7a00d6c0ad2b5e4f3ddfde0d076393d208d92be274ba3cb9553c.
- Stephanie S. Okey: Director, Nominating and Governance · Chair. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fd5013e6bfde7a00d6c0ad2b5e4f3ddfde0d076393d208d92be274ba3cb9553c.
- Christine Utter: Senior Vice President, Chief Accounting Officer & Head of People Services. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:853d07ca0301cd115cc4a6d98cf6103ccaa61bea65ec2932aaf23915bd7642f6.
- Eric Pauwels: Chief Business Officer. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2c038fbe2b6162c7624314b3f7aa1a0e0f1ee73ebd60df9541b8a0bc42cdddd1.
- Jane Baj: Vice President of Corporate Communications. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:052b616455e65f69149cf88cc3dc02940ab25a0ccffcb7045c5dfbef830bec1c.
- Lee Golden: Executive Vice President & Chief Medical Officer. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a46bad25279a93afa168a25521c1b882c562ddb2e8d1a4bcce97a6ef8a93567d.
- Linda Montella Carter: Senior VP & Chief Information Officer. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2f539daac17de57e2f55a0ae62b70f3927b83a7d93cf9b91b8ccbabb0dac2357.
- Mark Elliott Boulding: Executive VP & Chief Legal Officer. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2fe329eedfb6fffda501aeb7666d810383598f48c044a6989d6e6a305b9f67e3.
- Mark Klein: Chief Executive Officer. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:17. Valid from: 2026-04-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:114cfd42a722a1ef5fdf05f2ecdaadd98263e01edf2fd1aeee169689a68b9376.
- Matthew Klein: CEO & Director. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0e2ff3a55f47896998985bcb8636abccb82fb7c9228620df550aed38509b8930.
- Neil Almstead: Chief Technical Operations Officer. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:78fa619ffabb08cb532d9f1dd4afb88933e1348df99160d06af350b7823b7ab2.
- Pierre Gravier: Chief Financial Officer. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:13eb84c79525e3d685004cb6e833d5256fffbec4b99dfd007ac8eb186cfb2370.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- Nominating and Governance: Chair Stephanie S. Okey; Members Stephanie S. Okey (Chair); Jerome B. Zeldis. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dd98422bedce736d3393e3e2646be28ee77cdc2d734af292219f17e68fc0b441.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- PTC THERAPEUTICS, INC.. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:365061147ab33a003c97ccc0b036cca09ac4a27a5d4ac24271b1b57f8f1c2f83.

## Entity Status

- Public listing published. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:365061147ab33a003c97ccc0b036cca09ac4a27a5d4ac24271b1b57f8f1c2f83.

## Published Fact

- US. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:365061147ab33a003c97ccc0b036cca09ac4a27a5d4ac24271b1b57f8f1c2f83.
- Healthcare. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:365061147ab33a003c97ccc0b036cca09ac4a27a5d4ac24271b1b57f8f1c2f83.

## Committee Appointment

- Stephanie S. Okey: chair, Nominating and Governance. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dd98422bedce736d3393e3e2646be28ee77cdc2d734af292219f17e68fc0b441.
- Jerome B. Zeldis: member, Nominating and Governance. Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dd98422bedce736d3393e3e2646be28ee77cdc2d734af292219f17e68fc0b441.

## Security Listing

- PTCT (NASDAQ). Claim: alpha:claim:company:8ca7a0f6-5501-480b-8f48-1b9871fc788c:security_listing:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:365061147ab33a003c97ccc0b036cca09ac4a27a5d4ac24271b1b57f8f1c2f83.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:365061147ab33a003c97ccc0b036cca09ac4a27a5d4ac24271b1b57f8f1c2f83: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/ptc-therapeutics-inc).
- alpha:projection-evidence:document:fd5013e6bfde7a00d6c0ad2b5e4f3ddfde0d076393d208d92be274ba3cb9553c: [PTC Therapeutics DEF 14A 2026-04-20](https://www.sec.gov/Archives/edgar/data/1070081/000110465926045528/tmb-20260602xdef14a.htm).
- alpha:projection-evidence:document:853d07ca0301cd115cc4a6d98cf6103ccaa61bea65ec2932aaf23915bd7642f6: [PTC Therapeutics key executives](https://financialmodelingprep.com/stable/key-executives?symbol=PTCT).
- alpha:projection-evidence:document:2c038fbe2b6162c7624314b3f7aa1a0e0f1ee73ebd60df9541b8a0bc42cdddd1: [PTC Therapeutics key executives](https://financialmodelingprep.com/stable/key-executives?symbol=PTCT).
- alpha:projection-evidence:document:052b616455e65f69149cf88cc3dc02940ab25a0ccffcb7045c5dfbef830bec1c: [PTC Therapeutics key executives](https://financialmodelingprep.com/stable/key-executives?symbol=PTCT).
- alpha:projection-evidence:document:a46bad25279a93afa168a25521c1b882c562ddb2e8d1a4bcce97a6ef8a93567d: [PTC Therapeutics key executives](https://financialmodelingprep.com/stable/key-executives?symbol=PTCT).
- alpha:projection-evidence:document:2f539daac17de57e2f55a0ae62b70f3927b83a7d93cf9b91b8ccbabb0dac2357: [PTC Therapeutics key executives](https://financialmodelingprep.com/stable/key-executives?symbol=PTCT).
- alpha:projection-evidence:document:2fe329eedfb6fffda501aeb7666d810383598f48c044a6989d6e6a305b9f67e3: [PTC Therapeutics key executives](https://financialmodelingprep.com/stable/key-executives?symbol=PTCT).
- alpha:projection-evidence:document:114cfd42a722a1ef5fdf05f2ecdaadd98263e01edf2fd1aeee169689a68b9376: [PTCT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1070081/000110465926045528/tmb-20260602xdef14a.htm).
- alpha:projection-evidence:document:0e2ff3a55f47896998985bcb8636abccb82fb7c9228620df550aed38509b8930: [PTC Therapeutics key executives](https://financialmodelingprep.com/stable/key-executives?symbol=PTCT).
- alpha:projection-evidence:document:78fa619ffabb08cb532d9f1dd4afb88933e1348df99160d06af350b7823b7ab2: [PTC Therapeutics key executives](https://financialmodelingprep.com/stable/key-executives?symbol=PTCT).
- alpha:projection-evidence:document:13eb84c79525e3d685004cb6e833d5256fffbec4b99dfd007ac8eb186cfb2370: [PTC Therapeutics key executives](https://financialmodelingprep.com/stable/key-executives?symbol=PTCT).
- alpha:projection-evidence:dd98422bedce736d3393e3e2646be28ee77cdc2d734af292219f17e68fc0b441: [Nominating and Governance](https://www.sec.gov/Archives/edgar/data/1070081/000110465926045528/tmb-20260602xdef14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/ptc-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/ptc-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/ptc-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/ptc-therapeutics-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Structured intelligence is not currently available. Existing published profile evidence remains accessible.

## Critical-risk oversight

Snapshot as of 2026-11-13T08:09:33.109907+00:00; recorded 2026-11-13T08:09:33.109907+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.